← Leaderboards
Hyun-Sik Yang
Brigham And Women'S Hospital
$4,853,164
Attributed
$4,853,164
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,853,164 · 2
By mechanism
R01$3,870,802 · 1
K23$982,362 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Carl-Fredrik Westin$18,707,712
- Joshua M Shulman$14,788,000
- Tracy L Young-Pearse$25,012,544
- Ron Kikinis$27,906,567
- Towfique Raj$16,954,166
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS DiseaseTranscriptome SequencingPreventSamplingTranscriptomeGene ExpressionFunctional DisorderMapsPathologyRisk VariantDementiaTau ProteinsTherapeutic TargetAffectGenesResearch Project GrantsFutureCell TypeCommunitiesNerve DegenerationParticipantTranscriptomicsUnited States National Institutes Of Health
Grant awards (8)
Molecular and cellular underpinnings of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC)$1,346,438
R01 · FY2025 · AG · contact PI
Molecular and cellular underpinnings of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC)$1,228,351
R01 · FY2024 · AG · contact PI
Molecular and cellular underpinnings of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC)$1,296,013
R01 · FY2023 · AG · contact PI
Immunogenetic contribution to the progression of preclinical Alzheimer's disease$195,070
K23 · FY2023 · AG · contact PI
Immunogenetic contribution to the progression of preclinical Alzheimer's disease$197,554
K23 · FY2022 · AG · contact PI
Immunogenetic contribution to the progression of preclinical Alzheimer's disease$196,775
K23 · FY2021 · AG · contact PI
Immunogenetic contribution to the progression of preclinical Alzheimer's disease$195,940
K23 · FY2020 · AG · contact PI
Immunogenetic contribution to the progression of preclinical Alzheimer's disease$197,023
K23 · FY2019 · AG · contact PI